Back to Screener

Healthcare

Inhibrx Biosciences, Inc.(INBX)

Live Price

Offline

$94.73

-0.61% today

1Y Change

+557.03%

Window

Jun 27, 2025 โ†’ Jun 26, 2026

Market Cap
$1.89B
Revenue Growth
+550.0%
EPS Growth
-107.8%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 27, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Inhibrx Biosciences, Inc. (INBX) is a Healthcare stock with a market cap of $1.89B and listed on NASDAQ. The stock last traded around $94.73 and up 557.0% across the available one-year price window (Jun 27, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +550.0%, EPS growth of -107.8%, a dividend yield of 0.0%. What stands out right now is revenue +550.0%, EPS -107.8%, free cash flow +34.1% with operating margin -10386.5% and ROIC -117.4%. Valuation already assumes a fairly strong business story at price/sales 1451.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines INBX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

INBX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

INBX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

INBX Max Drawdown

-38.66%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for INBX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 13, 26
โ€”
Est -1.20
โ€”
โ€”
Est โ€”
โ€”
May 13
โ€”
Mar 19, 26
โœ—
-2.11
Est -2.08
-1.4%
โ€”
Est 1108.0B
โ€”
Mar 19
โ€”
Nov 14, 25
โœ—
-2.28
Est -2.08
-9.6%
โ€”
Est โ€”
โ€”
Nov 14
โ€”
Aug 13, 25
โœ“
-1.85
Est -2.92
+36.6%
1300.0B
Est โ€”
โ€”
Aug 13
โ€”
May 14, 25
โœ—
-2.80
Est -2.55
-9.8%
โ€”
Est โ€”
โ€”
May 14
โ€”
Mar 17, 25
โœ—
-3.09
Est -2.88
-7.3%
100.0B
Est โ€”
โ€”
Mar 17
โ€”
Nov 14, 24
โœ“
-2.84
Est -3.06
+7.2%
โ€”
Est โ€”
โ€”
Nov 14
โ€”
Aug 13, 24
โœ“
125.48
Est -3.60
+3585.6%
100.0B
Est โ€”
โ€”
Aug 13
โ€”
Jun 3, 24
โœ—
-1.44
Est -1.04
-38.5%
โ€”
Est 50.0B
โ€”
Jun 3
โ€”
Feb 28, 24
โœ—
-1.73
Est -1.07
-61.7%
1634.0B
Est 50.0B
+3168.0%
Feb 28
โ€”
Nov 9, 23
โœ—
-1.10
Est -1.01
-8.9%
119.0B
Est 50.0B
+138.0%
Nov 9
โ€”
Aug 7, 23
โœ—
-1.08
Est -1.02
-5.9%
30.0B
Est โ€”
โ€”
Aug 7
โ€”
May 8, 23
โœ—
-1.12
Est -0.84
-33.3%
17.0B
Est 150.0B
-88.7%
May 8
โ€”
Mar 6, 23
โœ—
-0.95
Est -0.80
-18.8%
274.0B
Est 994.0B
-72.4%
Mar 6
โ€”
Nov 7, 22
โœ“
-0.90
Est -1.01
+10.9%
278.0B
Est 633.3B
-56.1%
Nov 7
โ€”
Aug 8, 22
โœ—
-0.97
Est -0.84
-15.5%
711.0B
Est 1069.3B
-33.5%
Aug 8
โ€”
May 9, 22
โœ—
-0.80
Est -0.62
-29.0%
915.0B
Est 1102.6B
-17.0%
May 9
โ€”
Feb 28, 22
โœ—
-0.55
Est -0.53
-3.8%
2836.0B
Est 1208.3B
+134.7%
Feb 28
โ€”
Nov 9, 21
โœ“
-0.54
Est -0.57
+5.3%
2508.0B
Est 1500.0B
+67.2%
Nov 9
โ€”
Aug 9, 21
โœ—
-0.55
Est -0.51
-7.8%
918.0B
Est 820.0B
+11.9%
Aug 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar